Drug Shortage Report for ACT CELECOXIB

Last updated on 2018-10-11 History
Report ID 3390
Drug Identification Number 02420155
Brand name ACT CELECOXIB
Common or Proper name CELECOXIB
Company Name TEVA CANADA LIMITED
Active Ingredient(s) CELECOXIB
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-09-30
Estimated end date 2018-02-05
Actual end date 2018-02-15
Shortage status Resolved
Updated date 2018-10-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-10-11 French Compare
v9 2018-10-11 English Compare
v8 2017-10-10 French Compare
v7 2017-10-10 English Compare
v6 2017-05-10 French Compare
v5 2017-05-10 English Compare
v4 2017-03-18 English Compare
v3 2017-03-17 French Compare
v2 2017-03-17 English Compare
v1 2017-03-17 English Compare